ALLOY THERAPEUTICS
Alloy Therapeutics makes medicine by democratizing access to foundational drug discovery platforms and services. Alloy-Gx, its first platform, is a royalty-free suite of immunocompetent transgenic mice enabling best-in-class in vivo human antibody discovery. Founded in 2017, Alloy Therapeutics is headquartered in Waltham, Massachusetts.
ALLOY THERAPEUTICS
Industry:
Biopharma Biotechnology Life Science Therapeutics
Founded:
2017-01-01
Status:
Active
Total Funding:
128.25 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics LetsEncrypt Amazon
Similar Organizations
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Board_member
2021-02-01
Board_member
Current Employees Featured
Martin Leach Chief Operating Officer @ Alloy Therapeutics
Chief Operating Officer
2023-06-01
Trier Bryant President of Venture Studio, 82VS @ Alloy Therapeutics
President of Venture Studio, 82VS
2022-07-01
Michael Schmidt Chief Scientific Officer @ Alloy Therapeutics
Chief Scientific Officer
2023-05-01
John Lippincott Senior Vice President Therapeutic Discovery Strategies @ Alloy Therapeutics
Senior Vice President Therapeutic Discovery Strategies
2023-04-01
Errik Anderson Founder, Chairman and CEO @ Alloy Therapeutics
Founder, Chairman and CEO
2017-07-01
Richard Shimkets SVP Genetics and New Technologies @ Alloy Therapeutics
SVP Genetics and New Technologies
2021-06-01
Kent Bondensgaard Senior Vice President - Antibody Discovery Services @ Alloy Therapeutics
Senior Vice President - Antibody Discovery Services
2023-04-01
Joshua Brandt Associate General Counsel @ Alloy Therapeutics
Associate General Counsel
2021-07-01
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-09 | deepCDR Biologics | deepCDR Biologics acquired by Alloy Therapeutics | N/A |
Investors List
8VC
8VC investment in Series D - Alloy Therapeutics
Presight Capital
Presight Capital investment in Series D - Alloy Therapeutics
Founders Fund
Founders Fund investment in Series D - Alloy Therapeutics
Thiel Capital
Thiel Capital investment in Series D - Alloy Therapeutics
Mubadala Capital Ventures
Mubadala Capital Ventures investment in Series D - Alloy Therapeutics
8VC
8VC investment in Series C - Alloy Therapeutics
Bossanova Investimentos
Bossanova Investimentos investment in Series C - Alloy Therapeutics
Gaingels
Gaingels investment in Series C - Alloy Therapeutics
Luma Bio-IT
Luma Bio-IT investment in Series C - Alloy Therapeutics
Mubadala Capital Ventures
Mubadala Capital Ventures investment in Series C - Alloy Therapeutics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-10-04 | Wheeler Bio | Alloy Therapeutics investment in Series A - Wheeler Bio | 31 M USD |
| 2022-06-02 | Vernal Biosciences | Alloy Therapeutics investment in Series A - Vernal Biosciences | 21 M USD |
| 2022-04-06 | Tegmine Therapeutics | Alloy Therapeutics investment in Corporate Round - Tegmine Therapeutics | N/A |
| 2022-03-08 | Mytide Therapeutics | Alloy Therapeutics investment in Series A - Mytide Therapeutics | 7 M USD |
| 2022-01-04 | Wheeler Bio | Alloy Therapeutics investment in Seed Round - Wheeler Bio | 14 M USD |
| 2021-07-21 | Wheeler Bio | Alloy Therapeutics investment in Seed Round - Wheeler Bio | N/A |
| 2021-07-12 | Vernal Biosciences | Alloy Therapeutics investment in Seed Round - Vernal Biosciences | N/A |
Key Employee Changes
More informations about "Alloy Therapeutics"
Alloy Therapeutics - Crunchbase Investor Profile
Alloy Therapeutics makes medicine by democratizing access to foundational drug discovery platforms and services. Alloy-Gx, its first platform, is a royalty-free …See details»
Alloy Therapeutics (Switzerland) AG – Swiss Biotech
Alloy Therapeutics is a biotechnology ecosystem company democratizing access to tools, technologies, and services for discovering and developing therapeutic biologics across six modalities, including antibodies, TCRs, genetic medicines, …See details»
Alloy Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
BOSTON--( BUSINESS WIRE )--Alloy Therapeutics Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug discovery technologies, …See details»
Alloy Therapeutics and Wheeler Bio Announce …
BOSTON, Nov. 8, 2023 /PRNewswire/ -- Alloy Therapeutics, Inc., a biotechnology ecosystem company and Wheeler Bio, Inc., an agile contract development and manufacturing organization (CDMO ...See details»
Alloy Therapeutics UK Ltd - One Nucleus
Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners across …See details»
Alloy Therapeutics Democratizes Access to Biologics …
Nov 4, 2022 Alloy Therapeutics also works in peptides, cell therapy, and drug delivery. ... “When you come with a lot of data, the support of a whole organization, and all our infrastructure at 82VS and ...See details»
Alloy Therapeutics Establishes Multi-Year Collaboration with Pfizer …
Feb 11, 2025 Alloy is dedicated to reinvesting its revenue into innovation and has continuously expanded its murine platforms, adding new strains such as ATX-GL TM with the full human …See details»
Advancing Therapeutic Discovery Together
Alloy Therapeutics Announces New Licensing Model for ATX-Gx™ Antibody Discovery Platform and Launches mAbForge™ High-Throughput Screening Service. Learn more. Press Releases; Alloy Therapeutics Announces a Target …See details»
Alloy Therapeutics and Wheeler Bio Announce Preferred
Nov 8, 2023 Alloy Therapeutics, Inc., a biotechnology ecosystem company and Wheeler Bio, Inc., an agile contract development and manufacturing organization, announced the formation …See details»
Making better medicines by breaking down barriers to translation
Alloy Therapeutics was founded in 2017 to create an ecosystem in which scientists from pharma, small and medium-sized biotechs, and academia alike would have equal access to …See details»
Alloy Therapeutics to empower drug discovery of Lundbeck’s …
May 2, 2023 Alloy quickly followed with its Antibody Discovery Service organization to enable its collaborators to fully outsource their discovery services needs to the foremost experts on the …See details»
EVOTEC PARTNERS WITH ALLOY THERAPEUTICS TO EXPAND ITS …
Alloy Therapeutics is a biotechnology company dedicated to empowering scientists in the relentless pursuit of making better medicines for all. To this end, Alloy seeks to democratize …See details»
Alloy Therapeutics LLC - Drug pipelines, Patents, Clinical trials
This follows on from a November 2024 agreement with Alloy Therapeutics to develop chimeric antigen receptor (CAR)-T therapies using Takeda’s proprietary induced pluripotent stem cell …See details»
Alloy's Drug Discovery Technologies & Services Roadmap - Alloy …
Alloy reinvests 100% of its revenue into innovation and access to innovation, a commitment that enables the organization to continuously improve upon and develop new technologies to …See details»
Alloy Therapeutics Enters Japanese Market by Establishing …
1 day ago BOSTON--(BUSINESS WIRE)--Ypsilon Therapeutics, a portfolio company of 82VS, Alloy’s venture studio, has been awarded $2.7 million in seed funding from CPRIT.Ypsilon will …See details»
Alloy Therapeutics Announces Target Specific Collaboration with …
Boston, MA, January 7th, 2025 – Alloy Therapeutics Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug discovery technologies, …See details»
米アロイ・セラピューティクス、湘南ヘルスイノベーションパー …
3 days ago Alloy Therapeutics, Inc.のプレスリリース（2025年5月20日 16時00分）米アロイ・セラピューティクス、湘南ヘルスイノベーションパークに新拠点を設立See details»
Boston & New England Biotech Companies - Pharmaceuticals, …
Alloy Therapeutics : MA - Waltham: Antibody Discovery Platform: Alltrna : MA - Cambridge: tRNA therapies: Allurion Technologies : MA - Natick: Gastric Balloon: Allyx Therapeutics : ... Mispro …See details»
AlloMek Company Profile - Office Locations, Competitors ... - Craft
AlloMek is a company focusing on therapeutics for cardiomyopathy and congenital muscular disease caused by LMNA genetic mutations. It develops macrocyclic small molecule MEK …See details»
Alloy Therapeutics Enters Japanese Market by Establishing
1 day ago Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners …See details»